Antibiotics are no longer able to treat infections as effectively as they once did because many pathogens have developed ...

India's common infections are becoming untreatable as widely used antibiotics lose efficacy, according to a new ICMR report.

GSK funding allocated to six new research programmes which will combine expertise and using cutting edge AI technology to accelerate research to tackle antimicrobial resistance (AMR).

India faces a growing crisis as common infections become increasingly difficult to treat due to widespread antibiotic ...

Blacksmith Medicines receives European patent for LpxC-targeting antibacterial compounds: San Diego, California Tuesday, November 25, 2025, 16:00 Hrs [IST] Blacksmith Medicines, I ...

Researchers have designed a chemical phototherapy tool that when exposed to blue light damages an enzyme found in ...

Wockhardt shares surge as US FDA accepts first-ever NDA from an Indian pharma company for new antibiotic Zaynich, aimed at ...

The spread of resistance genes like NDM, OXA-48, and TEM among bacteria is also a significant concern, as it could lead to the emergence of new superbugs. Hence, the ICMR report warns that if ...

Pfizer announced the introduction of a novel treatment in the United Arab Emirates for adult patients with serious Gram-negative bacterial infections in the United Arab Emirates. This milestone marks ...

Zaynich targets complicated urinary tract infections (cUTIs) caused by multi-drug resistant (MDR) gram-negative bacteria.

Researchers employed a technique that can allow the discovery of novel microbiome-produced metabolites not seen under standard laboratory conditions.

The study analyzed a specific sample of used products that were collected from Virginia schools between 2024 and 2025.